High expression of LOXL1 in cancer-associated fibroblasts (CAFs) has been shown to enhance NSCLC tumorigenicity [33] (Table 2), while increased LOX activity also helps promote increased invasion and migration of NSCLC [123] (Table 2). The gene discussed is LOX; the disease is non-small cell lung carcinoma.